Newsfeeds - Spark Newswire

2 minute read

Forian Stock Trading Higher On Selling Its Cannabis Software Subsidiary & CEO Stepping Down

February 13, 11:07 AM

Forian Inc. (NASDAQ: FORA) announced the sale of its cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., effective February 10, 2023, for a total purchase price of $30

FORA

2 minute read

Forian Announces The Sale Of BioTrack To Alleaves For A Total Purchase Price Of $30M In Cash

By Happy Mohamed

February 13, 10:12 AM

Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and data science driven solutions, today announced the sale of Forian's cannabis software subsidiary, Bio-Tech Medical Software, Inc.

FORA

4 minute read

Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

December 21, 2:51 PM

Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical machining.

ADPT

2 minute read

Reported Late Tuesday, New York Selects Forian’s Biotrack As The State’s Cannabis Seed To Sale Track And Trace System

By Benzinga Newsdesk

December 21, 1:53 AM

Forian Inc. (NASDAQ:FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, today announced that New York has selected BioTrack as the track and trace

FORA

1 minute read

Forian Q3 EPS $(0.16) Beats $(0.17) Estimate, Sales $7.18M Beat $6.67M Estimate

By Benzinga Newsdesk

November 14, 5:30 PM

Forian (NASDAQ:FORA) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.17) by 5.88 percent. This is a 27.27 percent increase over losses of $(0.22) per share from the same

FORA

17 minute read

Earnings

Earnings Scheduled For November 14, 2022

By Benzinga Insights

November 14, 6:06 AM

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

AAIC

5 minute read

Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday

By Lisa Levin

September 19, 1:53 AM

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.

AAOI

2 minute read

BLAZE Receives SOC 1 Certification

By Vuk Zdinjak

August 17, 9:55 AM

Cannabis software company BLAZE Solutions, Inc. validated its data performance and implementation and gained SOC 1 Certification.

FORA

1 minute read

Forian Q2 Revenue Grows 44% YoY, Here Are The Details

By Vuk Zdinjak

August 12, 9:12 AM

Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022. Q2 2022 Financial Highlights

FORA

1 minute read

Forian Q2 Sales $6.50M Beat $6.18M Estimate

By Benzinga Newsdesk

August 11, 4:30 PM

Forian (NASDAQ:FORA) reported quarterly sales of $6.50 million which beat the analyst consensus estimate of $6.18 million by 5.18 percent. This is a 42.92 percent increase over sales of $4.55 million the same period

FORA